Literature DB >> 15717274

TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer.

Alina Deshpande1, John P Nolan, P Scott White, Yolanda E Valdez, William C Hunt, Cheri L Peyton, Cosette M Wheeler.   

Abstract

BACKGROUND: Polymorphisms in the TNF-alpha promoter region have recently been shown to be associated with susceptibility to cervical cancer. Some polymorphisms have been reported to influence transcription for this cytokine. Altered local levels in the cervix may influence an individual's immune response, thereby affecting persistence of human papillomavirus (HPV) 16 infection, a primary etiological factor for cervical cancer. METHODS AND
RESULTS: The association of 11 TNF-alpha single-nucleotide polymorphisms (SNPs) with susceptibility to HPV16-associated cervical cancer was investigated. Sequencing of the TNF-alpha promoter region confirmed 10 SNPs, and 1 previously unreported SNP (161 bp upstream of the transcriptional start site) was discovered. Microsphere-array flow cytometry-based genotyping was performed on 787 samples from Hispanic and non-Hispanic white women (241 from randomly selected control subjects, 205 from HPV16-positive control subjects, and 341 from HPV16-positive subjects with cervical cancer). The genotype distribution of 3 SNPs (-572, -857, and -863) was significantly different between case subjects and control subjects. Analysis of haplotypes, which were computationally inferred from genotype data, also revealed statistically significant differences in haplotype distribution between case subjects and control subjects.
CONCLUSIONS: We report new associations between several TNF-alpha SNPs and susceptibility to cervical cancer that support the involvement of the TNF- alpha promoter region in development of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717274     DOI: 10.1086/427826

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

1.  Associations of TNF-A-1031TT and -857TT genotypes with Helicobacter pylori seropositivity and gastric atrophy among Japanese Brazilians.

Authors:  Yoshiko Atsuta; Lucy S Ito; Sueli M Oba-Shinjo; Miyuki Uno; Samuel Katsuyuki Shinjo; Suely K N Marie; Yasuyuki Goto; Nobuyuki Hamajima
Journal:  Int J Clin Oncol       Date:  2006-04       Impact factor: 3.402

2.  Association between circulating interleukin-1 beta (IL-1β) levels and IL-1β C-511T polymorphism with cervical cancer risk in Egyptian women.

Authors:  Magdy A Al-Tahhan; Rasha L Etewa; Manal M El Behery
Journal:  Mol Cell Biochem       Date:  2011-03-23       Impact factor: 3.396

3.  TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk.

Authors:  Gisela Barbisan; Luis Orlando Pérez; Anahí Contreras; Carlos Daniel Golijow
Journal:  Tumour Biol       Date:  2012-05-17

4.  Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.

Authors:  Caiyun Zhang; Erich M Sturgis; Hongliang Zheng; Xicheng Song; Peng Wei; Lei Jin; Li Chao; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2013-10-24       Impact factor: 7.396

5.  Association between tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical cancer.

Authors:  Lanling Wang; Kunpeng Ma; Zhiyong Wang; Yingying Mou; Li Ma; Yong Guo
Journal:  Int J Clin Exp Med       Date:  2015-02-15

6.  Polymorphisms in immune mediators associate with risk of cervical cancer.

Authors:  Zhengyan Zhang; Samantha Fye; Ingrid B Borecki; Janet S Rader
Journal:  Gynecol Oncol       Date:  2014-08-12       Impact factor: 5.482

7.  A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer.

Authors:  Hua-Lian Zhang; Yi-Jie Zhang
Journal:  Tumour Biol       Date:  2013-03-15

8.  Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.

Authors:  S N Maley; S M Schwartz; L G Johnson; M Malkki; Q Du; J R Daling; S S Li; L P Zhao; E W Petersdorf; M M Madeleine
Journal:  Int J Immunogenet       Date:  2009-09-24       Impact factor: 1.466

9.  Interleukin-1 beta-511 polymorphism and risk of cervical cancer.

Authors:  Sokbom Kang; Jae Weon Kim; Noh Hyun Park; Yong Sang Song; Sang Yoon Park; Soon Beom Kang; Hyo Pyo Lee
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

Review 10.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.